Abstract:Timely relief of edema and clearance of waste products, as well as promotion of anti-inflammatory immune responses, reduce ischemic stroke pathology, and attenuate harmful long-term effects post-stroke. The discovery of an extensive and functional lymphatic vessel system in the outermost meningeal layer, dura mater, has opened up new possibilities to facilitate post-stroke recovery by inducing dural lymphatic vessel (dLV) growth via a single injection of a vector encoding vascular endothelial growth factor C (VEGF-C). In the present study, we aimed to improve post-stroke outcomes by inducing dLV growth in mice. We injected mice with a single intracerebroventricular dose of adeno-associated viral particles encoding VEGF-C before subjecting them to transient middle cerebral artery occlusion (tMCAo). Behavioral testing, Gadolinium (Gd) contrast agent-enhanced magnetic resonance imaging (MRI), and immunohistochemical analysis were performed to define the impact of VEGF-C on the post-stroke outcome. VEGF-C improved stroke-induced behavioral deficits, such as gait disturbances and neurological deficits, ameliorated post-stroke inflammation, and enhanced an alternative glial immune response. Importantly, VEGF-C treatment increased the drainage of brain interstitial fluid (ISF) and cerebrospinal fluid (CSF), as shown by Gd-enhanced MRI. These outcomes were closely associated with an increase in the growth of dLVs around the region where we observed increased vefgc mRNA expression within the brain, including the olfactory bulb, cortex, and cerebellum. Strikingly, VEGF-C-treated ischemic mice exhibited a faster and stronger Gd-signal accumulation in ischemic core area and an enhanced fluid outflow via the cribriform plate. In conclusion, the VEGF-C-induced dLV growth improved the overall outcome post-stroke, indicating that VEGF-C has potential to be included in the treatment strategies of post-ischemic stroke. However, to maximize the therapeutic potential of VEGF-C treatment, further studies on the impact of an enhanced dural lymphatic system at clinically relevant time points are essential.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is: **Improve the pathological conditions and behavioral outcomes after ischemic stroke by inducing the growth of dural lymphatic vessels (dLV)**. Specifically, the study aims to explore whether vascular endothelial growth factor C (VEGF - C) can improve problems such as brain edema, inflammatory response, and waste clearance after stroke after promoting the growth of dural lymphatic vessels, thereby enhancing the recovery effect after stroke. ### Research Background and Problem Statement 1. **Pathological Mechanisms of Ischemic Stroke** - Ischemic stroke can lead to the death of brain cells, which in turn causes sensorimotor and cognitive dysfunctions. - In the early stage of stroke, brain edema and necrotic cell death occur, and these are important risk factors for the morbidity and mortality of stroke patients. - After stroke, the circulation and excretion of interstitial fluid (ISF) and cerebrospinal fluid (CSF) are significantly reduced, affecting waste clearance, which is crucial for brain homeostasis. 2. **Role of Dural Lymphatic Vessels** - Recent studies have found that there is a functional lymphatic vessel system in the dura mater that can clear fluids, solutes, and wastes in the brain. - VEGF - C is a key regulator of lymphangiogenesis and can drive the development and expansion of dural lymphatic vessels in adulthood. 3. **Research Hypothesis** - Stimulating lymphangiogenesis by overexpressing VEGF - C may help improve brain edema and waste accumulation problems in acute brain injury. - The anti - inflammatory and neurogenic effects of VEGF - C may provide additional benefits during neuroinflammation. ### Research Objectives - **Primary Objective**: Evaluate whether VEGF - C - induced dural lymphatic vessel growth can improve the circulation of ISF and CSF after ischemic stroke, thereby providing neuroprotection and improving behavioral outcomes. - **Secondary Objective**: Investigate the specific effects of VEGF - C on the inflammatory response, neuronal damage, and waste clearance after stroke. ### Experimental Design To verify the above hypotheses, the researchers conducted the following experiments: 1. **Animal Model**: Young male mice (6 - 8 weeks old) were used and divided into multiple cohorts for experiments. 2. **VEGF - C Injection**: AAV9 viral vectors encoding VEGF - C or control viruses were injected intracerebroventricularly and treated 14 or 35 days before the stroke surgery. 3. **Stroke Model**: The transient middle cerebral artery occlusion (tMCAo) model was used to simulate stroke. 4. **Behavioral Tests**: Including gait analysis, neurological scoring, movement delay tests, etc., to evaluate behavioral changes after stroke. 5. **Imaging Examinations**: Gadolinium - enhanced magnetic resonance imaging (Gd - enhanced MRI) was used to evaluate brain tissue edema and perfusion. 6. **Immunohistochemical Analysis**: Detect the effects of VEGF - C on gene expression in different brain regions, as well as on the inflammatory response and neuronal regeneration. ### Conclusions The study shows that VEGF - C - induced dural lymphatic vessel growth does improve behavioral deficits after stroke, reduce the inflammatory response, and enhance the drainage of interstitial fluid and cerebrospinal fluid. These results indicate that VEGF - C has potential application value in stroke treatment, but further research is still needed on its effects at clinically relevant time points. ### Keywords - VEGF - C - Ischemic Stroke - Dura Mater - Lymphatic Vessel - Lymph Through these studies, the authors hope to provide new ideas and methods for the future development of more effective stroke treatment strategies.

The Impact of VEGF-C-Induced Dural Lymphatic Vessel Growth on Ischemic Stroke Pathology

VEGF-C prophylaxis favors lymphatic drainage and modulates neuroinflammation in a stroke model

VEGF Promotes Angiogenesis and Functional Recovery in Stroke Rats.

The dose-effectiveness of intranasal VEGF in treatment of experimental stroke.

VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia

Abstract 117: Stromal Cell-derived Factor-1 Gene Modified Endothelial Progenitor Cell Effectively Attenuated Ischemic Brain Injury in Mouse Model

Vascular Endothelial Growth Factor Augments the Tolerance Towards Cerebral Stroke by Enhancing Neurovascular Repair Mechanism

VEGF Ameliorates Cognitive Impairment in In Vivo and In Vitro Ischemia via Improving Neuronal Viability and Function

Effects of Vascular Endothelial Growth Factor in Ischemic Stroke

Abstract WP94: Delayed SDF-1 Hyperexpression Promotes Neural Stem Cell Migration and Maturation Without Increasing Inflammation after Ischemic Stroke in Mice

Postacute Stromal Cell–Derived Factor-1α Expression Promotes Neurovascular Recovery in Ischemic Mice

The novel VEGF receptor antagonist, VGA1155, reduces edema, decreases infarct and improves neurological function after stroke in rats

Impaired meningeal lymphatic vessel development worsens stroke outcome

Microneedle-mediated vascular endothelial growth factor delivery promotes angiogenesis and functional recovery after stroke

VEGF overexpression enhances striatal neurogenesis in brain of adult rat after a transient middle cerebral artery occlusion.

The Janus Face of VEGF in Stroke

Intraventricular Vascular Endothelial Growth Factor Antibody Increases Infarct Volume Following Transient Cerebral Ischemia.

Intraventricular Injection of Liposome-Mediated VEGF Plasmids Enhances Brain Repair Following Ischemia-Reperfusion Injury

Combined VEGF and Bfgf Loaded Nanofiber Membrane Protects Against Neuronal Injury and Hypomyelination in a Rat Model of Chronic Cerebral Hypoperfusion

Vascular Endothelial Growth Factor in Cerebral Ischemia

VEGF attenuates 2-VO induced cognitive impairment and neuronal injury associated with the activation of PI3K/Akt and Notch1 pathway.